FdaApplication

NDA 022418

Back to search

Identifiers

Properties

PropertyValue
applicant_nameROSEMONT PHARMACEUTICALS LLC
application_typeNDA
approval_date2009-08-14

Products (2)

ProductActive ingredientStrengthDosage form
FIBRICORFENOFIBRIC ACID35MGTABLET;ORAL
FIBRICORFENOFIBRIC ACID105MGTABLET;ORAL

2 products